Brief: Rein Therapeutics Inc Prices Public Offering Of 50 Million Shares At $1.00 Per Share For $50 Million
01/05/2026 01:01
April 30 (Reuters) - Rein Therapeutics Inc RNTX.O: REIN THERAPEUTICS ANNOUNCES PRICING OF $50 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK REIN THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 50 MILLION SHARES AT $1.00 PER SHARE FOR $50 MILLION Source text: ID:nGNXbX4Ffm Further company coverage: RNTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering